Is OSCR in Good Health? Oscar Health (NYSE:OSCR) is a technology-driven health insurance company specializing in individual, ...

Fintel reports that on July 2, 2025, UBS downgraded their outlook for Centene (NYSE:CNC) from Buy to Neutral. Analyst Price Forecast Suggests 36.47% Upside As of June 20, 2025, the average one-year ...

Fintel reports that on July 16, 2025, B of A Securities downgraded their outlook for Centene (NYSE:CNC) from Neutral to ...

Shares of Centene are trading lower on Thursday, hitting a new 52-week low. A rival's profit warning fueled investor anxiety ...

Nearly a week ago, shares of Centene closed down 40.4%, making it the largest single-day drop since the company went public ...

Investing.com -- Shares of Centene (NYSE:CNC) plunged more than 32% in premarket trading Wednesday after the company pulled its 2025 guidance, citing unexpectedly poor risk adjustment results in ...

Shares of Centene are experiencing a historic collapse this week. Wednesday marked the worst single-day performance in the company's history.

Centene's Fair Value Cut, Uncertainty Rating Downgraded on Individual Plan and Medicaid Headwinds Julie Utterback Jul 2, 2025 Share ...

Meanwhile, Barclays downgraded Centene from Overweight to Equalweight, expressing concerns about the Part D and ACA segments and adjusting their earnings per share estimates downward for 2025 and ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research ...

Centene's stock was suffering a record 39.2% selloff in recent trading, as a miscalculation of rising healthcare costs led the company to withdraw its full-year earnings outlook.

Centene pulled its financial outlook for the rest of the year after learning that enrollees in its Affordable Care Act plans got more health care than expected.